245 related articles for article (PubMed ID: 36107559)
41. The medical management of reflux esophagitis. Role of antacids and acid inhibition.
Sontag SJ
Gastroenterol Clin North Am; 1990 Sep; 19(3):683-712. PubMed ID: 1977703
[TBL] [Abstract][Full Text] [Related]
42. [Application of the recommendations of the conference of consensus in front of symptoms ENT, respiratory or thoracic pains considered as due to a gastroesophageal reflux disease].
Vallot T; Ducrotte P; Bour B; Jacques JP; Houcke P; De Korwin JD; Pariente A; Aygalenq P; Coudsy B; Carrois F; Ricci L; Bruley des Varannes S
Presse Med; 2013 May; 42(5):e125-32. PubMed ID: 23414966
[TBL] [Abstract][Full Text] [Related]
43. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
van Pinxteren B; Numans ME; Bonis PA; Lau J
Cochrane Database Syst Rev; 2006 Jul; (3):CD002095. PubMed ID: 16855986
[TBL] [Abstract][Full Text] [Related]
44. Review article: treatment of mild and severe cases of GERD.
Tytgat GN
Aliment Pharmacol Ther; 2002 Jul; 16 Suppl 4():73-8. PubMed ID: 12047264
[TBL] [Abstract][Full Text] [Related]
45. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
van Pinxteren B; Numans ME; Bonis PA; Lau J
Cochrane Database Syst Rev; 2004 Oct; (4):CD002095. PubMed ID: 15495027
[TBL] [Abstract][Full Text] [Related]
46. Treatment patterns in paediatric patients with a new diagnosis of gastroesophageal reflux disease.
Ruigómez A; Hungin AP; Lundborg P; Johansson S; Wallander MA; García Rodríguez LA
Eur J Gastroenterol Hepatol; 2011 Mar; 23(3):232-7. PubMed ID: 21258240
[TBL] [Abstract][Full Text] [Related]
47. Treatment of intermittent reflux symptoms: one size does not fit all.
DeVault KR
J Clin Gastroenterol; 2007 Jul; 41(6):546-7. PubMed ID: 17577109
[No Abstract] [Full Text] [Related]
48. A Review of Histamine-2 Receptor Antagonist and Proton Pump Inhibitor Therapy for Gastroesophageal Reflux Disease in Neonates and Infants.
Tan J; Jeffries S; Carr R
Paediatr Drugs; 2023 Sep; 25(5):557-576. PubMed ID: 37458926
[TBL] [Abstract][Full Text] [Related]
49. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
van Pinxteren B; Numans ME; Bonis PA; Lau J
Cochrane Database Syst Rev; 2000; (2):CD002095. PubMed ID: 10796857
[TBL] [Abstract][Full Text] [Related]
50. Review article: alginate-raft formulations in the treatment of heartburn and acid reflux.
Mandel KG; Daggy BP; Brodie DA; Jacoby HI
Aliment Pharmacol Ther; 2000 Jun; 14(6):669-90. PubMed ID: 10848650
[TBL] [Abstract][Full Text] [Related]
51. Review: treatment of gastroesophageal reflux disease in the elderly.
Poh CH; Navarro-Rodriguez T; Fass R
Am J Med; 2010 Jun; 123(6):496-501. PubMed ID: 20569750
[TBL] [Abstract][Full Text] [Related]
52. Evidence-based treatment of frequent heartburn: the benefits and limitations of over-the-counter medications.
McRorie JW; Gibb RD; Miner PB
J Am Assoc Nurse Pract; 2014 Jun; 26(6):330-9. PubMed ID: 24825071
[TBL] [Abstract][Full Text] [Related]
53. Gastroesophageal reflux disease (GERD): is there more to the story?
Vesper BJ; Altman KW; Elseth KM; Haines GK; Pavlova SI; Tao L; Tarjan G; Radosevich JA
ChemMedChem; 2008 Apr; 3(4):552-9. PubMed ID: 18076011
[TBL] [Abstract][Full Text] [Related]
54. Interventions for preventing upper gastrointestinal bleeding in people admitted to intensive care units.
Toews I; George AT; Peter JV; Kirubakaran R; Fontes LES; Ezekiel JPB; Meerpohl JJ
Cochrane Database Syst Rev; 2018 Jun; 6(6):CD008687. PubMed ID: 29862492
[TBL] [Abstract][Full Text] [Related]
55. Randomised clinical trial: the clinical efficacy and safety of an alginate-antacid (Gaviscon Double Action) versus placebo, for decreasing upper gastrointestinal symptoms in symptomatic gastroesophageal reflux disease (GERD) in China.
Sun J; Yang C; Zhao H; Zheng P; Wilkinson J; Ng B; Yuan Y
Aliment Pharmacol Ther; 2015 Oct; 42(7):845-54. PubMed ID: 26228097
[TBL] [Abstract][Full Text] [Related]
56. Role of the primary care provider in the diagnosis and management of heartburn.
Kushner PR
Curr Med Res Opin; 2010 Apr; 26(4):759-65. PubMed ID: 20095795
[TBL] [Abstract][Full Text] [Related]
57. Recent Advances in the Pharmacological Management of Gastroesophageal Reflux Disease.
Kung YM; Hsu WH; Wu MC; Wang JW; Liu CJ; Su YC; Kuo CH; Kuo FC; Wu DC; Wang YK
Dig Dis Sci; 2017 Dec; 62(12):3298-3316. PubMed ID: 29110162
[TBL] [Abstract][Full Text] [Related]
58. Gastroesophageal reflux disease: exaggerations, evidence and clinical practice.
Ferreira CT; Carvalho Ed; Sdepanian VL; Morais MB; Vieira MC; Silva LR
J Pediatr (Rio J); 2014; 90(2):105-18. PubMed ID: 24184302
[TBL] [Abstract][Full Text] [Related]
59. GERD: Diagnosing and treating the burn.
Alzubaidi M; Gabbard S
Cleve Clin J Med; 2015 Oct; 82(10):685-92. PubMed ID: 26469826
[TBL] [Abstract][Full Text] [Related]
60. Gastroesophageal reflux disease. Control of symptoms, prevention of complications.
Kaynard A; Flora K
Postgrad Med; 2001 Sep; 110(3):42-4, 47-8, 51-3. PubMed ID: 11570205
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]